Astrana Health, agilon health, Guardant Health, AdaptHealth, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know

stock_story_highlight
08/14

What Happened?

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index $(CPI.UK)$ report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth-oriented sectors like healthcare, as they reduce the cost of borrowing for research and innovation and increase the present value of future earnings.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

  • Healthcare Technology for Providers company Astrana Health (NASDAQ:ASTH) jumped 3.3%. Is now the time to buy Astrana Health? Access our full analysis report here, it’s free.
  • Outpatient & Specialty Care company agilon health (NYSE:AGL) jumped 20.2%. Is now the time to buy agilon health? Access our full analysis report here, it’s free.
  • Testing & Diagnostics Services company Guardant Health (NASDAQ:GH) jumped 5.8%. Is now the time to buy Guardant Health? Access our full analysis report here, it’s free.
  • Senior Health, Home Health & Hospice company AdaptHealth $(AHCO)$ jumped 3.1%. Is now the time to buy AdaptHealth? Access our full analysis report here, it’s free.
  • Specialized Medical & Nursing Services company Pediatrix Medical Group (NYSE:MD) jumped 5.3%. Is now the time to buy Pediatrix Medical Group? Access our full analysis report here, it’s free.

Zooming In On agilon health $(AGL.UK)$

agilon health’s shares are extremely volatile and have had 80 moves greater than 5% over the last year. But moves this big are rare even for agilon health and indicate this news significantly impacted the market’s perception of the business.

agilon health is down 46.3% since the beginning of the year, and at $1.03 per share, it is trading 81.9% below its 52-week high of $5.68 from April 2025. Investors who bought $1,000 worth of agilon health’s shares at the IPO in April 2021 would now be looking at an investment worth $33.23.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft $(MSFT)$ to Alphabet $(GOOG)$, Coca-Cola $(KO)$ to Monster Beverage $(MNST)$ could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10